Cocrystal Pharma (NASDAQ:COCP) Price Target Cut to $10.00 by Analysts at HC Wainwright
Cocrystal Pharma (NASDAQ:COCP – Free Report) had its target price reduced by HC Wainwright from $12.00 to $10.00 in a report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Cocrystal Pharma’s Q4 2023 earnings at ($0.58) EPS, FY2023 earnings at ($2.01) EPS, Q1 […]
More Stories
I Will Find You: Sam Worthington’s Upcoming Series
Netflix is coming up with an all-new miniseries featuring the famous Sam Worthington as Jake Sully from the 2009 film...
Big Mistakes Season 2: Release Date, Cast, and Synopsis
Netflix’s hit comedy-thriller series, Big Mistakes, got an official renewal. The dark comedy series is bringing back the humor of...
Top 11 E-Commerce Companies in the USA for Your Convenience
There are a huge number of e-commerce companies in the USA. These companies are growing exponentially with the increasing demand....
Strip Law Season 2 Renewed? Check out the Renewal Status
Netflix is cancelling one series after another, and Strip Law, the American adult animated sitcom, is among them. Netflix has...
Netflix’s Upcoming Drama, Husbands in Action, is Releasing Soon
Are you also a Korean drama lover? If yes, Good news! An all-new comedy drama is arriving soon on Netflix....
The Witness, TV Series: Release Date, Cast, Trailer, and Plot
Netflix’s upcoming documentary and television series are based on the real-life murder of Rachel Nickell in 1992. The Witness is...